EULAV Asset Management’s Allergan Inc AGN Stock Holding History

EULAV Asset Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-49,000	Closed	-$10.4M	–	353
2014 Q4	$10.4M	Sell	49,000 -30,000	-38%	-$5.97M	0.56%	62
2014 Q3	$14.1M	Sell	79,000 -9,600	-11%	-$1.59M	0.77%	20
2014 Q2	$15M	Hold	88,600	–	–	0.8%	18
2014 Q1	$11M	Sell	88,600 -5,000	-5%	-$609K	0.6%	51
2013 Q4	$10.4M	Hold	93,600	–	–	0.57%	60
2013 Q3	$8.47M	Buy	93,600 +14,000	+18%	+$1.26M	0.49%	70
2013 Q2	$6.71M	Buy	+79,600	New	+$8.26M	0.41%	85

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

EULAV Asset Management's AGN Position: Q1 2015 in Review

EULAV Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 49,000 shares — an estimated $10.4M sold.

EULAV Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $15M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

EULAV Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
EULAV Asset Management sold 49,000 Allergan Inc shares in Q1 2015, an estimated $10.4M.
EULAV Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
EULAV Asset Management's Allergan Inc position peaked at $15M in Q2 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on EULAV Asset Management's 13F filing for Q1 2015, filed 28 Apr 2015.